Skip Nav Destination
Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A
Free
Issue Archive
Table of Contents
INSIDE BLOOD COMMENTARIES
PERSPECTIVES
HOW I TREAT
CLINICAL TRIALS AND OBSERVATIONS
Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A
Free
Clinical Trials & Observations
Barbara A. Konkle,Oleksandra Stasyshyn,Pratima Chowdary,David H. Bevan,Tim Mant,Midori Shima,Werner Engl,Jacqueline Dyck-Jones,Monika Fuerlinger,Lisa Patrone,Bruce Ewenstein,Brigitt Abbuehl
HEMATOPOIESIS AND STEM CELLS
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts Free
Jerome Paggetti,Franziska Haderk,Martina Seiffert,Bassam Janji,Ute Distler,Wim Ammerlaan,Yeoun Jin Kim,Julien Adam,Peter Lichter,Eric Solary,Guy Berchem,Etienne Moussay
MYELOID NEOPLASIA
PLATELETS AND THROMBOPOIESIS
TRANSPLANTATION
BLOOD WORK
-
Cover Image
Cover Image
A multinucleated megakaryocyte, a sign of myelodysplasia in mouse bone marrow. See the article by Zhou et al on page 1057.
- PDF Icon Front MatterFront Matter
- PDF Icon Table of ContentsTable of Contents
- PDF Icon Back MatterBack Matter
- PDF Icon AdvertisingAdvertising
- PDF Icon Editorial BoardEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals